Literature DB >> 16894068

Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.

Matthias H Tabert1, Jennifer J Manly, Xinhua Liu, Gregory H Pelton, Sara Rosenblum, Marni Jacobs, Diana Zamora, Madeleine Goodkind, Karen Bell, Yaakov Stern, D P Devanand.   

Abstract

CONTEXT: The likelihood of conversion to Alzheimer disease (AD) in mild cognitive impairment (MCI) and the "optimal" early markers of conversion need to be established.
OBJECTIVES: To evaluate conversion rates to AD in subtypes of MCI and to identify neuropsychological measures most predictive of the time to conversion.
DESIGN: Patients were followed up semiannually and controls annually. Subtypes of MCI were determined by using demographically adjusted regression norms on neuropsychological tests. Survival analysis was used to identify the most predictive neuropsychological measures.
SETTING: Memory disorders clinic. PARTICIPANTS: One hundred forty-eight patients reporting memory problems and 63 group-matched controls. MAIN OUTCOME MEASURE: A consensus diagnosis of probable AD.
RESULTS: At baseline, 108 patients met criteria for amnestic MCI: 87 had memory plus other cognitive domain deficits and 21 had pure memory deficits. The mean duration of follow-up for the 148 patients was 46.6 +/- 24.6 months. In 3 years, 32 (50.0%) of 64 amnestic-"plus" and 2 (10.0%) of 20 "pure" amnestic patients converted to AD (P = .001). In 148 patients, of 5 a priori predictors, the percent savings from immediate to delayed recall on the Selective Reminding Test and the Wechsler Adult Intelligence Scale-Revised Digit Symbol Test were the strongest predictors of time to conversion. From the entire neuropsychological test battery, a stepwise selection procedure retained 2 measures in the final model: total immediate recall on the Selective Reminding Test (odds ratio per 1-point decrease, 1.10; 95% confidence interval, 1.05-1.14; P < .0001) and Digit Symbol Test coding (odds ratio, 1.06; 95% confidence interval, 1.01-1.11; P = .01). The combined predictive accuracy of these 2 measures for conversion by 3 years was 86%.
CONCLUSIONS: Mild cognitively impaired patients with memory plus other cognitive domain deficits, rather than those with pure amnestic MCI, constituted the high-risk group. Deficits in verbal memory and psychomotor speed/executive function abilities strongly predicted conversion to AD.

Entities:  

Mesh:

Year:  2006        PMID: 16894068     DOI: 10.1001/archpsyc.63.8.916

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  189 in total

Review 1.  Changes in cognition.

Authors:  Marilyn S Albert
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

2.  Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

3.  A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer's disease.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Georgina Vinyes-Junqué; Ana Espinosa; Sergi Valero; Isabel Hernández; Isabel Roca; Agustín Ruíz; Maitée Rosende-Roca; Ana Mauleón; James T Becker; Joan Castell-Conesa; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods.

Authors:  Robert M Chapman; Mark Mapstone; John W McCrary; Margaret N Gardner; Anton Porsteinsson; Tiffany C Sandoval; Maria D Guillily; Elizabeth Degrush; Lindsey A Reilly
Journal:  J Clin Exp Neuropsychol       Date:  2010-08-13       Impact factor: 2.475

5.  Performance-based measures of everyday function in mild cognitive impairment.

Authors:  Terry E Goldberg; Jeremy Koppel; Lynda Keehlisen; Erica Christen; Ute Dreses-Werringloer; Concepcion Conejero-Goldberg; Marc L Gordon; Peter Davies
Journal:  Am J Psychiatry       Date:  2010-04-01       Impact factor: 18.112

6.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

7.  Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.

Authors:  Montserrat Alegret; Gemma Cuberas-Borrós; Ana Espinosa; Sergi Valero; Isabel Hernández; Agustín Ruíz; James T Becker; Maitée Rosende-Roca; Ana Mauleón; Oscar Sotolongo; Joan Castell-Conesa; Isabel Roca; Lluís Tárraga; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease.

Authors:  D P Devanand; Ravi Bansal; Jun Liu; Xuejun Hao; Gnanavalli Pradhaban; Bradley S Peterson
Journal:  Neuroimage       Date:  2012-01-25       Impact factor: 6.556

9.  Lead exposure and rate of change in cognitive function in older women.

Authors:  Melinda C Power; Susan Korrick; Eric J Tchetgen Tchetgen; Linda H Nie; Francine Grodstein; Howard Hu; Jennifer Weuve; Joel Schwartz; Marc G Weisskopf
Journal:  Environ Res       Date:  2014-01-29       Impact factor: 6.498

10.  Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data.

Authors:  Kan Li; Wenyaw Chan; Rachelle S Doody; Joseph Quinn; Sheng Luo
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.